sales@marketresearchvision.com

30 mins free consultation for each report        Upto 50% Discounts for Highest selling reports


Global Opioid Induced Constipation (OIC) Drug Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global Opioid Induced Constipation (OIC) Drug Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Category : Pharmaceuticals and Healthcare QY Research Pages :150
Published Date : 2020-12-28

 

Covid-19

COVID-19

Understand the influence of COVID-19 on the Opioid Induced Constipation OIC Drug Market with our analysts monitoring the situation across the globe.
Opioid Induced Constipation (OIC) Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Opioid Induced Constipation (OIC) Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2027. Segment by Type, the Opioid Induced Constipation (OIC) Drug market is segmented into Lubiprostone Methyl Naltrexone Bromide Naldemedine Alvimopan Other Segment by Application, the Opioid Induced Constipation (OIC) Drug market is segmented into Hospital Pharmacies Retail Pharmacies Online Pharmacies Regional and Country-level Analysis The Opioid Induced Constipation (OIC) Drug market is analysed and market size information is provided by regions (countries). The key regions covered in the Opioid Induced Constipation (OIC) Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. The report includes country-wise and region-wise market size for the period 2015-2027. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2027. Competitive Landscape and Opioid Induced Constipation (OIC) Drug Market Share Analysis Opioid Induced Constipation (OIC) Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2021. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2021. Details included are company description, major business, company total revenue and the sales, revenue generated in Opioid Induced Constipation (OIC) Drug business, the date to enter into the Opioid Induced Constipation (OIC) Drug market, Opioid Induced Constipation (OIC) Drug product introduction, recent developments, etc. The major vendors covered: Ironwood Pharmaceuticals Daiichi Sankyo Co Pfizer Progenics Pharmaceuticals Shionogi & Allergan Nektar Therapeutics Purdue Pharma S.L.A. Pharma Mundipharma International Limited Ono Pharmaceutical Takeda Pharmaceutical Company Limited Theravance Biopharma Bausch Health Cosmo Pharmaceuticals SA Daewoong Pharmaceutical C.B. Fleet Company Sucampo Pharmaceuticals
1 Study Coverage 1.1 Opioid Induced Constipation (OIC) Drug Product Introduction 1.2 Market Segments 1.3 Key Opioid Induced Constipation (OIC) Drug Manufacturers Covered: Ranking by Revenue 1.4 Market by Type 1.4.1 Global Opioid Induced Constipation (OIC) Drug Market Size Growth Rate by Type 1.4.2 Lubiprostone 1.4.3 Methyl Naltrexone Bromide 1.4.4 Naldemedine 1.4.5 Alvimopan 1.4.6 Other 1.5 Market by Application 1.5.1 Global Opioid Induced Constipation (OIC) Drug Market Size Growth Rate by Application 1.5.2 Hospital Pharmacies 1.5.3 Retail Pharmacies 1.5.4 Online Pharmacies 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Opioid Induced Constipation (OIC) Drug Market Size, Estimates and Forecasts 2.1.1 Global Opioid Induced Constipation (OIC) Drug Revenue 2015-2027 2.1.2 Global Opioid Induced Constipation (OIC) Drug Sales 2015-2027 2.2 Global Opioid Induced Constipation (OIC) Drug, Market Size by Producing Regions: 2015 VS 2021 VS 2027 2.2.1 Global Opioid Induced Constipation (OIC) Drug Retrospective Market Scenario in Sales by Region: 2015-2021 2.2.2 Global Opioid Induced Constipation (OIC) Drug Retrospective Market Scenario in Revenue by Region: 2015-2021 3 Global Opioid Induced Constipation (OIC) Drug Competitor Landscape by Players 3.1 Opioid Induced Constipation (OIC) Drug Sales by Manufacturers 3.1.1 Opioid Induced Constipation (OIC) Drug Sales by Manufacturers (2015-2021) 3.1.2 Opioid Induced Constipation (OIC) Drug Sales Market Share by Manufacturers (2015-2021) 3.2 Opioid Induced Constipation (OIC) Drug Revenue by Manufacturers 3.2.1 Opioid Induced Constipation (OIC) Drug Revenue by Manufacturers (2015-2021) 3.2.2 Opioid Induced Constipation (OIC) Drug Revenue Share by Manufacturers (2015-2021) 3.2.3 Global Opioid Induced Constipation (OIC) Drug Market Concentration Ratio (CR5 and HHI) (2015-2021) 3.2.4 Global Top 10 and Top 5 Companies by Opioid Induced Constipation (OIC) Drug Revenue in 2019 3.2.5 Global Opioid Induced Constipation (OIC) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Opioid Induced Constipation (OIC) Drug Price by Manufacturers 3.4 Opioid Induced Constipation (OIC) Drug Manufacturing Base Distribution, Product Types 3.4.1 Opioid Induced Constipation (OIC) Drug Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Opioid Induced Constipation (OIC) Drug Product Type 3.4.3 Date of International Manufacturers Enter into Opioid Induced Constipation (OIC) Drug Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Market Size by Type (2015-2027) 4.1 Global Opioid Induced Constipation (OIC) Drug Market Size by Type (2015-2021) 4.1.1 Global Opioid Induced Constipation (OIC) Drug Sales by Type (2015-2021) 4.1.2 Global Opioid Induced Constipation (OIC) Drug Revenue by Type (2015-2021) 4.1.3 Opioid Induced Constipation (OIC) Drug Average Selling Price (ASP) by Type (2015-2027) 4.2 Global Opioid Induced Constipation (OIC) Drug Market Size Forecast by Type (2021-2027) 4.2.1 Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Type (2021-2027) 4.2.2 Global Opioid Induced Constipation (OIC) Drug Revenue Forecast by Type (2021-2027) 4.2.3 Opioid Induced Constipation (OIC) Drug Average Selling Price (ASP) Forecast by Type (2021-2027) 4.3 Global Opioid Induced Constipation (OIC) Drug Market Share by Price Tier (2015-2021): Low-End, Mid-Range and High-End 5 Market Size by Application (2015-2027) 5.1 Global Opioid Induced Constipation (OIC) Drug Market Size by Application (2015-2021) 5.1.1 Global Opioid Induced Constipation (OIC) Drug Sales by Application (2015-2021) 5.1.2 Global Opioid Induced Constipation (OIC) Drug Revenue by Application (2015-2021) 5.1.3 Opioid Induced Constipation (OIC) Drug Price by Application (2015-2021) 5.2 Opioid Induced Constipation (OIC) Drug Market Size Forecast by Application (2021-2027) 5.2.1 Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Application (2021-2027) 5.2.2 Global Opioid Induced Constipation (OIC) Drug Revenue Forecast by Application (2021-2027) 5.2.3 Global Opioid Induced Constipation (OIC) Drug Price Forecast by Application (2021-2027) 6 North America 6.1 North America Opioid Induced Constipation (OIC) Drug by Country 6.1.1 North America Opioid Induced Constipation (OIC) Drug Sales by Country 6.1.2 North America Opioid Induced Constipation (OIC) Drug Revenue by Country 6.1.3 U.S. 6.1.4 Canada 6.2 North America Opioid Induced Constipation (OIC) Drug Market Facts & Figures by Type 6.3 North America Opioid Induced Constipation (OIC) Drug Market Facts & Figures by Application 7 Europe 7.1 Europe Opioid Induced Constipation (OIC) Drug by Country 7.1.1 Europe Opioid Induced Constipation (OIC) Drug Sales by Country 7.1.2 Europe Opioid Induced Constipation (OIC) Drug Revenue by Country 7.1.3 Germany 7.1.4 France 7.1.5 U.K. 7.1.6 Italy 7.1.7 Russia 7.2 Europe Opioid Induced Constipation (OIC) Drug Market Facts & Figures by Type 7.3 Europe Opioid Induced Constipation (OIC) Drug Market Facts & Figures by Application 8 Asia Pacific 8.1 Asia Pacific Opioid Induced Constipation (OIC) Drug by Region 8.1.1 Asia Pacific Opioid Induced Constipation (OIC) Drug Sales by Region 8.1.2 Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue by Region 8.1.3 China 8.1.4 Japan 8.1.5 South Korea 8.1.6 India 8.1.7 Australia 8.1.8 Taiwan 8.1.9 Indonesia 8.1.10 Thailand 8.1.11 Malaysia 8.1.12 Philippines 8.1.13 Vietnam 8.2 Asia Pacific Opioid Induced Constipation (OIC) Drug Market Facts & Figures by Type 8.3 Asia Pacific Opioid Induced Constipation (OIC) Drug Market Facts & Figures by Application 9 Latin America 9.1 Latin America Opioid Induced Constipation (OIC) Drug by Country 9.1.1 Latin America Opioid Induced Constipation (OIC) Drug Sales by Country 9.1.2 Latin America Opioid Induced Constipation (OIC) Drug Revenue by Country 9.1.3 Mexico 9.1.4 Brazil 9.1.5 Argentina 9.2 Central & South America Opioid Induced Constipation (OIC) Drug Market Facts & Figures by Type 9.3 Central & South America Opioid Induced Constipation (OIC) Drug Market Facts & Figures by Application 10 Middle East and Africa 10.1 Middle East and Africa Opioid Induced Constipation (OIC) Drug by Country 10.1.1 Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales by Country 10.1.2 Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue by Country 10.1.3 Turkey 10.1.4 Saudi Arabia 10.1.5 U.A.E 10.2 Middle East and Africa Opioid Induced Constipation (OIC) Drug Market Facts & Figures by Type 10.3 Middle East and Africa Opioid Induced Constipation (OIC) Drug Market Facts & Figures by Application 11 Company Profiles 11.1 Ironwood Pharmaceuticals 11.1.1 Ironwood Pharmaceuticals Corporation Information 11.1.2 Ironwood Pharmaceuticals Description and Business Overview 11.1.3 Ironwood Pharmaceuticals Sales, Revenue and Gross Margin (2015-2021) 11.1.4 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Products Offered 11.1.5 Ironwood Pharmaceuticals Related Developments 11.2 Daiichi Sankyo Co 11.2.1 Daiichi Sankyo Co Corporation Information 11.2.2 Daiichi Sankyo Co Description and Business Overview 11.2.3 Daiichi Sankyo Co Sales, Revenue and Gross Margin (2015-2021) 11.2.4 Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Products Offered 11.2.5 Daiichi Sankyo Co Related Developments 11.3 Pfizer 11.3.1 Pfizer Corporation Information 11.3.2 Pfizer Description and Business Overview 11.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2021) 11.3.4 Pfizer Opioid Induced Constipation (OIC) Drug Products Offered 11.3.5 Pfizer Related Developments 11.4 Progenics Pharmaceuticals 11.4.1 Progenics Pharmaceuticals Corporation Information 11.4.2 Progenics Pharmaceuticals Description and Business Overview 11.4.3 Progenics Pharmaceuticals Sales, Revenue and Gross Margin (2015-2021) 11.4.4 Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Products Offered 11.4.5 Progenics Pharmaceuticals Related Developments 11.5 Shionogi & 11.5.1 Shionogi & Corporation Information 11.5.2 Shionogi & Description and Business Overview 11.5.3 Shionogi & Sales, Revenue and Gross Margin (2015-2021) 11.5.4 Shionogi & Opioid Induced Constipation (OIC) Drug Products Offered 11.5.5 Shionogi & Related Developments 11.6 Allergan 11.6.1 Allergan Corporation Information 11.6.2 Allergan Description and Business Overview 11.6.3 Allergan Sales, Revenue and Gross Margin (2015-2021) 11.6.4 Allergan Opioid Induced Constipation (OIC) Drug Products Offered 11.6.5 Allergan Related Developments 11.7 Nektar Therapeutics 11.7.1 Nektar Therapeutics Corporation Information 11.7.2 Nektar Therapeutics Description and Business Overview 11.7.3 Nektar Therapeutics Sales, Revenue and Gross Margin (2015-2021) 11.7.4 Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Products Offered 11.7.5 Nektar Therapeutics Related Developments 11.8 Purdue Pharma 11.8.1 Purdue Pharma Corporation Information 11.8.2 Purdue Pharma Description and Business Overview 11.8.3 Purdue Pharma Sales, Revenue and Gross Margin (2015-2021) 11.8.4 Purdue Pharma Opioid Induced Constipation (OIC) Drug Products Offered 11.8.5 Purdue Pharma Related Developments 11.9 S.L.A. Pharma 11.9.1 S.L.A. Pharma Corporation Information 11.9.2 S.L.A. Pharma Description and Business Overview 11.9.3 S.L.A. Pharma Sales, Revenue and Gross Margin (2015-2021) 11.9.4 S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Products Offered 11.9.5 S.L.A. Pharma Related Developments 11.10 Mundipharma International Limited 11.10.1 Mundipharma International Limited Corporation Information 11.10.2 Mundipharma International Limited Description and Business Overview 11.10.3 Mundipharma International Limited Sales, Revenue and Gross Margin (2015-2021) 11.10.4 Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Products Offered 11.10.5 Mundipharma International Limited Related Developments 11.1 Ironwood Pharmaceuticals 11.1.1 Ironwood Pharmaceuticals Corporation Information 11.1.2 Ironwood Pharmaceuticals Description and Business Overview 11.1.3 Ironwood Pharmaceuticals Sales, Revenue and Gross Margin (2015-2021) 11.1.4 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Products Offered 11.1.5 Ironwood Pharmaceuticals Related Developments 11.12 Takeda Pharmaceutical Company Limited 11.12.1 Takeda Pharmaceutical Company Limited Corporation Information 11.12.2 Takeda Pharmaceutical Company Limited Description and Business Overview 11.12.3 Takeda Pharmaceutical Company Limited Sales, Revenue and Gross Margin (2015-2021) 11.12.4 Takeda Pharmaceutical Company Limited Products Offered 11.12.5 Takeda Pharmaceutical Company Limited Related Developments 11.13 Theravance Biopharma 11.13.1 Theravance Biopharma Corporation Information 11.13.2 Theravance Biopharma Description and Business Overview 11.13.3 Theravance Biopharma Sales, Revenue and Gross Margin (2015-2021) 11.13.4 Theravance Biopharma Products Offered 11.13.5 Theravance Biopharma Related Developments 11.14 Bausch Health 11.14.1 Bausch Health Corporation Information 11.14.2 Bausch Health Description and Business Overview 11.14.3 Bausch Health Sales, Revenue and Gross Margin (2015-2021) 11.14.4 Bausch Health Products Offered 11.14.5 Bausch Health Related Developments 11.15 Cosmo Pharmaceuticals SA 11.15.1 Cosmo Pharmaceuticals SA Corporation Information 11.15.2 Cosmo Pharmaceuticals SA Description and Business Overview 11.15.3 Cosmo Pharmaceuticals SA Sales, Revenue and Gross Margin (2015-2021) 11.15.4 Cosmo Pharmaceuticals SA Products Offered 11.15.5 Cosmo Pharmaceuticals SA Related Developments 11.16 Daewoong Pharmaceutical 11.16.1 Daewoong Pharmaceutical Corporation Information 11.16.2 Daewoong Pharmaceutical Description and Business Overview 11.16.3 Daewoong Pharmaceutical Sales, Revenue and Gross Margin (2015-2021) 11.16.4 Daewoong Pharmaceutical Products Offered 11.16.5 Daewoong Pharmaceutical Related Developments 11.17 C.B. Fleet Company 11.17.1 C.B. Fleet Company Corporation Information 11.17.2 C.B. Fleet Company Description and Business Overview 11.17.3 C.B. Fleet Company Sales, Revenue and Gross Margin (2015-2021) 11.17.4 C.B. Fleet Company Products Offered 11.17.5 C.B. Fleet Company Related Developments 11.18 Sucampo Pharmaceuticals 11.18.1 Sucampo Pharmaceuticals Corporation Information 11.18.2 Sucampo Pharmaceuticals Description and Business Overview 11.18.3 Sucampo Pharmaceuticals Sales, Revenue and Gross Margin (2015-2021) 11.18.4 Sucampo Pharmaceuticals Products Offered 11.18.5 Sucampo Pharmaceuticals Related Developments 12 Future Forecast by Regions (Countries) (2021-2027) 12.1 Opioid Induced Constipation (OIC) Drug Market Estimates and Projections by Region 12.1.1 Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Regions 2021-2027 12.1.2 Global Opioid Induced Constipation (OIC) Drug Revenue Forecast by Regions 2021-2027 12.2 North America Opioid Induced Constipation (OIC) Drug Market Size Forecast (2021-2027) 12.2.1 North America: Opioid Induced Constipation (OIC) Drug Sales Forecast (2021-2027) 12.2.2 North America: Opioid Induced Constipation (OIC) Drug Revenue Forecast (2021-2027) 12.2.3 North America: Opioid Induced Constipation (OIC) Drug Market Size Forecast by Country (2021-2027) 12.3 Europe Opioid Induced Constipation (OIC) Drug Market Size Forecast (2021-2027) 12.3.1 Europe: Opioid Induced Constipation (OIC) Drug Sales Forecast (2021-2027) 12.3.2 Europe: Opioid Induced Constipation (OIC) Drug Revenue Forecast (2021-2027) 12.3.3 Europe: Opioid Induced Constipation (OIC) Drug Market Size Forecast by Country (2021-2027) 12.4 Asia Pacific Opioid Induced Constipation (OIC) Drug Market Size Forecast (2021-2027) 12.4.1 Asia Pacific: Opioid Induced Constipation (OIC) Drug Sales Forecast (2021-2027) 12.4.2 Asia Pacific: Opioid Induced Constipation (OIC) Drug Revenue Forecast (2021-2027) 12.4.3 Asia Pacific: Opioid Induced Constipation (OIC) Drug Market Size Forecast by Region (2021-2027) 12.5 Latin America Opioid Induced Constipation (OIC) Drug Market Size Forecast (2021-2027) 12.5.1 Latin America: Opioid Induced Constipation (OIC) Drug Sales Forecast (2021-2027) 12.5.2 Latin America: Opioid Induced Constipation (OIC) Drug Revenue Forecast (2021-2027) 12.5.3 Latin America: Opioid Induced Constipation (OIC) Drug Market Size Forecast by Country (2021-2027) 12.6 Middle East and Africa Opioid Induced Constipation (OIC) Drug Market Size Forecast (2021-2027) 12.6.1 Middle East and Africa: Opioid Induced Constipation (OIC) Drug Sales Forecast (2021-2027) 12.6.2 Middle East and Africa: Opioid Induced Constipation (OIC) Drug Revenue Forecast (2021-2027) 12.6.3 Middle East and Africa: Opioid Induced Constipation (OIC) Drug Market Size Forecast by Country (2021-2027) 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Porter's Five Forces Analysis 13.5 Primary Interviews with Key Opioid Induced Constipation (OIC) Drug Players (Opinion Leaders) 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Opioid Induced Constipation (OIC) Drug Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

Get Free Sample

List of Tables Table 1. Opioid Induced Constipation (OIC) Drug Market Segments Table 2. Ranking of Global Top Opioid Induced Constipation (OIC) Drug Manufacturers by Revenue (US$ Million) in 2019 Table 3. Global Opioid Induced Constipation (OIC) Drug Market Size Growth Rate by Type 2021-2027 (K Units) & (US$ Million) Table 4. Major Manufacturers of Lubiprostone Table 5. Major Manufacturers of Methyl Naltrexone Bromide Table 6. Major Manufacturers of Naldemedine Table 7. Major Manufacturers of Alvimopan Table 8. Major Manufacturers of Other Table 9. Global Opioid Induced Constipation (OIC) Drug Market Size Growth Rate by Application 2021-2027 (K Units) Table 10. Global Opioid Induced Constipation (OIC) Drug Market Size by Region (K Units) & (US$ Million): 2021 VS 2027 Table 11. Global Opioid Induced Constipation (OIC) Drug Sales by Regions 2015-2021 (K Units) Table 12. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Regions (2015-2021) Table 13. Global Opioid Induced Constipation (OIC) Drug Revenue by Regions 2015-2021 (US$ Million) Table 14. Global Opioid Induced Constipation (OIC) Drug Sales by Manufacturers (2015-2021) (K Units) Table 15. Global Opioid Induced Constipation (OIC) Drug Sales Share by Manufacturers (2015-2021) Table 16. Global Opioid Induced Constipation (OIC) Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2021) Table 17. Global Opioid Induced Constipation (OIC) Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioid Induced Constipation (OIC) Drug as of 2019) Table 18. Opioid Induced Constipation (OIC) Drug Revenue by Manufacturers (2015-2021) (US$ Million) Table 19. Opioid Induced Constipation (OIC) Drug Revenue Share by Manufacturers (2015-2021) Table 20. Key Manufacturers Opioid Induced Constipation (OIC) Drug Price (2015-2021) (USD/Unit) Table 21. Opioid Induced Constipation (OIC) Drug Manufacturers Manufacturing Base Distribution and Headquarters Table 22. Manufacturers Opioid Induced Constipation (OIC) Drug Product Type Table 23. Date of International Manufacturers Enter into Opioid Induced Constipation (OIC) Drug Market Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans Table 25. Global Opioid Induced Constipation (OIC) Drug Sales by Type (2015-2021) (K Units) Table 26. Global Opioid Induced Constipation (OIC) Drug Sales Share by Type (2015-2021) Table 27. Global Opioid Induced Constipation (OIC) Drug Revenue by Type (2015-2021) (US$ Million) Table 28. Global Opioid Induced Constipation (OIC) Drug Revenue Share by Type (2015-2021) Table 29. Opioid Induced Constipation (OIC) Drug Average Selling Price (ASP) by Type 2015-2021 (USD/Unit) Table 30. Global Opioid Induced Constipation (OIC) Drug Sales by Application (2015-2021) (K Units) Table 31. Global Opioid Induced Constipation (OIC) Drug Sales Share by Application (2015-2021) Table 32. North America Opioid Induced Constipation (OIC) Drug Sales by Country (2015-2021) (K Units) Table 33. North America Opioid Induced Constipation (OIC) Drug Sales Market Share by Country (2015-2021) Table 34. North America Opioid Induced Constipation (OIC) Drug Revenue by Country (2015-2021) (US$ Million) Table 35. North America Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country (2015-2021) Table 36. North America Opioid Induced Constipation (OIC) Drug Sales by Type (2015-2021) (K Units) Table 37. North America Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2015-2021) Table 38. North America Opioid Induced Constipation (OIC) Drug Sales by Application (2015-2021) (K Units) Table 39. North America Opioid Induced Constipation (OIC) Drug Sales Market Share by Application (2015-2021) Table 40. Europe Opioid Induced Constipation (OIC) Drug Sales by Country (2015-2021) (K Units) Table 41. Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Country (2015-2021) Table 42. Europe Opioid Induced Constipation (OIC) Drug Revenue by Country (2015-2021) (US$ Million) Table 43. Europe Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country (2015-2021) Table 44. Europe Opioid Induced Constipation (OIC) Drug Sales by Type (2015-2021) (K Units) Table 45. Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2015-2021) Table 46. Europe Opioid Induced Constipation (OIC) Drug Sales by Application (2015-2021) (K Units) Table 47. Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Application (2015-2021) Table 48. Asia Pacific Opioid Induced Constipation (OIC) Drug Sales by Region (2015-2021) (K Units) Table 49. Asia Pacific Opioid Induced Constipation (OIC) Drug Sales Market Share by Region (2015-2021) Table 50. Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue by Region (2015-2021) (US$ Million) Table 51. Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue Market Share by Region (2015-2021) Table 52. Asia Pacific Opioid Induced Constipation (OIC) Drug Sales by Type (2015-2021) (K Units) Table 53. Asia Pacific Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2015-2021) Table 54. Asia Pacific Opioid Induced Constipation (OIC) Drug Sales by Application (2015-2021) (K Units) Table 55. Asia Pacific Opioid Induced Constipation (OIC) Drug Sales Market Share by Application (2015-2021) Table 56. Latin America Opioid Induced Constipation (OIC) Drug Sales by Country (2015-2021) (K Units) Table 57. Latin America Opioid Induced Constipation (OIC) Drug Sales Market Share by Country (2015-2021) Table 58. Latin Americaa Opioid Induced Constipation (OIC) Drug Revenue by Country (2015-2021) (US$ Million) Table 59. Latin America Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country (2015-2021) Table 60. Latin America Opioid Induced Constipation (OIC) Drug Sales by Type (2015-2021) (K Units) Table 61. Latin America Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2015-2021) Table 62. Latin America Opioid Induced Constipation (OIC) Drug Sales by Application (2015-2021) (K Units) Table 63. Latin America Opioid Induced Constipation (OIC) Drug Sales Market Share by Application (2015-2021) Table 64. Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales by Country (2015-2021) (K Units) Table 65. Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Country (2015-2021) Table 66. Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue by Country (2015-2021) (US$ Million) Table 67. Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country (2015-2021) Table 68. Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales by Type (2015-2021) (K Units) Table 69. Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2015-2021) Table 70. Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales by Application (2015-2021) (K Units) Table 71. Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Application (2015-2021) Table 72. Ironwood Pharmaceuticals Corporation Information Table 73. Ironwood Pharmaceuticals Description and Major Businesses Table 74. Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2021) Table 75. Ironwood Pharmaceuticals Product Table 76. Ironwood Pharmaceuticals Recent Development Table 77. Daiichi Sankyo Co Corporation Information Table 78. Daiichi Sankyo Co Description and Major Businesses Table 79. Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2021) Table 80. Daiichi Sankyo Co Product Table 81. Daiichi Sankyo Co Recent Development Table 82. Pfizer Corporation Information Table 83. Pfizer Description and Major Businesses Table 84. Pfizer Opioid Induced Constipation (OIC) Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2021) Table 85. Pfizer Product Table 86. Pfizer Recent Development Table 87. Progenics Pharmaceuticals Corporation Information Table 88. Progenics Pharmaceuticals Description and Major Businesses Table 89. Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2021) Table 90. Progenics Pharmaceuticals Product Table 91. Progenics Pharmaceuticals Recent Development Table 92. Shionogi & Corporation Information Table 93. Shionogi & Description and Major Businesses Table 94. Shionogi & Opioid Induced Constipation (OIC) Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2021) Table 95. Shionogi & Product Table 96. Shionogi & Recent Development Table 97. Allergan Corporation Information Table 98. Allergan Description and Major Businesses Table 99. Allergan Opioid Induced Constipation (OIC) Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2021) Table 100. Allergan Product Table 101. Allergan Recent Development Table 102. Nektar Therapeutics Corporation Information Table 103. Nektar Therapeutics Description and Major Businesses Table 104. Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2021) Table 105. Nektar Therapeutics Product Table 106. Nektar Therapeutics Recent Development Table 107. Purdue Pharma Corporation Information Table 108. Purdue Pharma Description and Major Businesses Table 109. Purdue Pharma Opioid Induced Constipation (OIC) Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2021) Table 110. Purdue Pharma Product Table 111. Purdue Pharma Recent Development Table 112. S.L.A. Pharma Corporation Information Table 113. S.L.A. Pharma Description and Major Businesses Table 114. S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2021) Table 115. S.L.A. Pharma Product Table 116. S.L.A. Pharma Recent Development Table 117. Mundipharma International Limited Corporation Information Table 118. Mundipharma International Limited Description and Major Businesses Table 119. Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2021) Table 120. Mundipharma International Limited Product Table 121. Mundipharma International Limited Recent Development Table 122. Ono Pharmaceutical Corporation Information Table 123. Ono Pharmaceutical Description and Major Businesses Table 124. Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2021) Table 125. Ono Pharmaceutical Product Table 126. Ono Pharmaceutical Recent Development Table 127. Takeda Pharmaceutical Company Limited Corporation Information Table 128. Takeda Pharmaceutical Company Limited Description and Major Businesses Table 129. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2021) Table 130. Takeda Pharmaceutical Company Limited Product Table 131. Takeda Pharmaceutical Company Limited Recent Development Table 132. Theravance Biopharma Corporation Information Table 133. Theravance Biopharma Description and Major Businesses Table 134. Theravance Biopharma Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2021) Table 135. Theravance Biopharma Product Table 136. Theravance Biopharma Recent Development Table 137. Bausch Health Corporation Information Table 138. Bausch Health Description and Major Businesses Table 139. Bausch Health Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2021) Table 140. Bausch Health Product Table 141. Bausch Health Recent Development Table 142. Cosmo Pharmaceuticals SA Corporation Information Table 143. Cosmo Pharmaceuticals SA Description and Major Businesses Table 144. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2021) Table 145. Cosmo Pharmaceuticals SA Product Table 146. Cosmo Pharmaceuticals SA Recent Development Table 147. Daewoong Pharmaceutical Corporation Information Table 148. Daewoong Pharmaceutical Description and Major Businesses Table 149. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2021) Table 150. Daewoong Pharmaceutical Product Table 151. Daewoong Pharmaceutical Recent Development Table 152. C.B. Fleet Company Corporation Information Table 153. C.B. Fleet Company Description and Major Businesses Table 154. C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2021) Table 155. C.B. Fleet Company Product Table 156. C.B. Fleet Company Recent Development Table 157. Sucampo Pharmaceuticals Corporation Information Table 158. Sucampo Pharmaceuticals Description and Major Businesses Table 159. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2021) Table 160. Sucampo Pharmaceuticals Product Table 161. Sucampo Pharmaceuticals Recent Development Table 162. Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Regions (2021-2027) (K Units) Table 163. Global Opioid Induced Constipation (OIC) Drug Sales Market Share Forecast by Regions (2021-2027) Table 164. Global Opioid Induced Constipation (OIC) Drug Revenue Forecast by Regions (2021-2027) (US$ Million) Table 165. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share Forecast by Regions (2021-2027) Table 166. North America: Opioid Induced Constipation (OIC) Drug Sales Forecast by Country (2021-2027) (K Units) Table 167. North America: Opioid Induced Constipation (OIC) Drug Revenue Forecast by Country (2021-2027) (US$ Million) Table 168. Europe: Opioid Induced Constipation (OIC) Drug Sales Forecast by Country (2021-2027) (K Units) Table 169. Europe: Opioid Induced Constipation (OIC) Drug Revenue Forecast by Country (2021-2027) (US$ Million) Table 170. Asia Pacific: Opioid Induced Constipation (OIC) Drug Sales Forecast by Region (2021-2027) (K Units) Table 171. Asia Pacific: Opioid Induced Constipation (OIC) Drug Revenue Forecast by Region (2021-2027) (US$ Million) Table 172. Latin America: Opioid Induced Constipation (OIC) Drug Sales Forecast by Country (2021-2027) (K Units) Table 173. Latin America: Opioid Induced Constipation (OIC) Drug Revenue Forecast by Country (2021-2027) (US$ Million) Table 174. Middle East and Africa: Opioid Induced Constipation (OIC) Drug Sales Forecast by Country (2021-2027) (K Units) Table 175. Middle East and Africa: Opioid Induced Constipation (OIC) Drug Revenue Forecast by Country (2021-2027) (US$ Million) Table 176. Key Opportunities and Drivers: Impact Analysis (2021-2027) Table 177. Key Challenges Table 178. Market Risks Table 179. Main Points Interviewed from Key Opioid Induced Constipation (OIC) Drug Players Table 180. Opioid Induced Constipation (OIC) Drug Customers List Table 181. Opioid Induced Constipation (OIC) Drug Distributors List Table 182. Research Programs/Design for This Report Table 183. Key Data Information from Secondary Sources Table 184. Key Data Information from Primary Sources List of Figures Figure 1. Opioid Induced Constipation (OIC) Drug Product Picture Figure 2. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Type in 2021 & 2027 Figure 3. Lubiprostone Product Picture Figure 4. Methyl Naltrexone Bromide Product Picture Figure 5. Naldemedine Product Picture Figure 6. Alvimopan Product Picture Figure 7. Other Product Picture Figure 8. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Application in 2021 & 2027 Figure 9. Hospital Pharmacies Figure 10. Retail Pharmacies Figure 11. Online Pharmacies Figure 12. Opioid Induced Constipation (OIC) Drug Report Years Considered Figure 13. Global Opioid Induced Constipation (OIC) Drug Market Size 2015-2027 (US$ Million) Figure 14. Global Opioid Induced Constipation (OIC) Drug Sales 2015-2027 (K Units) Figure 15. Global Opioid Induced Constipation (OIC) Drug Market Size Market Share by Region: 2021 Versus 2027 Figure 16. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Region (2015-2021) Figure 17. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Region in 2019 Figure 18. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Region (2015-2021) Figure 19. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Region in 2019 Figure 20. Global Opioid Induced Constipation (OIC) Drug Sales Share by Manufacturer in 2019 Figure 21. The Top 10 and 5 Players Market Share by Opioid Induced Constipation (OIC) Drug Revenue in 2019 Figure 22. Opioid Induced Constipation (OIC) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 23. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2015-2021) Figure 24. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Type in 2019 Figure 25. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Type (2015-2021) Figure 26. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Type in 2019 Figure 27. Global Opioid Induced Constipation (OIC) Drug Market Share by Price Range (2015-2021) Figure 28. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Application (2015-2021) Figure 29. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Application in 2019 Figure 30. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Application (2015-2021) Figure 31. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Application in 2019 Figure 32. North America Opioid Induced Constipation (OIC) Drug Sales Growth Rate 2015-2021 (K Units) Figure 33. North America Opioid Induced Constipation (OIC) Drug Revenue Growth Rate 2015-2021 (US$ Million) Figure 34. North America Opioid Induced Constipation (OIC) Drug Sales Market Share by Country in 2019 Figure 35. North America Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country in 2019 Figure 36. U.S. Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2015-2021) (K Units) Figure 37. U.S. Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2015-2021) (US$ Million) Figure 38. Canada Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2015-2021) (K Units) Figure 39. Canada Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2015-2021) (US$ Million) Figure 40. North America Opioid Induced Constipation (OIC) Drug Market Share by Type in 2019 Figure 41. North America Opioid Induced Constipation (OIC) Drug Market Share by Application in 2019 Figure 42. Europe Opioid Induced Constipation (OIC) Drug Sales Growth Rate 2015-2021 (K Units) Figure 43. Europe Opioid Induced Constipation (OIC) Drug Revenue Growth Rate 2015-2021 (US$ Million) Figure 44. Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Country in 2019 Figure 45. Europe Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country in 2019 Figure 46. Germany Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2015-2021) (K Units) Figure 47. Germany Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2015-2021) (US$ Million) Figure 48. France Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2015-2021) (K Units) Figure 49. France Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2015-2021) (US$ Million) Figure 50. U.K. Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2015-2021) (K Units) Figure 51. U.K. Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2015-2021) (US$ Million) Figure 52. Italy Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2015-2021) (K Units) Figure 53. Italy Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2015-2021) (US$ Million) Figure 54. Russia Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2015-2021) (K Units) Figure 55. Russia Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2015-2021) (US$ Million) Figure 56. Europe Opioid Induced Constipation (OIC) Drug Market Share by Type in 2019 Figure 57. Europe Opioid Induced Constipation (OIC) Drug Market Share by Application in 2019 Figure 58. Asia Pacific Opioid Induced Constipation (OIC) Drug Sales Growth Rate 2015-2021 (K Units) Figure 59. Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue Growth Rate 2015-2021 (US$ Million) Figure 60. Asia Pacific Opioid Induced Constipation (OIC) Drug Sales Market Share by Region in 2019 Figure 61. Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue Market Share by Region in 2019 Figure 62. China Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2015-2021) (K Units) Figure 63. China Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2015-2021) (US$ Million) Figure 64. Japan Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2015-2021) (K Units) Figure 65. Japan Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2015-2021) (US$ Million) Figure 66. South Korea Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2015-2021) (K Units) Figure 67. South Korea Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2015-2021) (US$ Million) Figure 68. India Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2015-2021) (K Units) Figure 69. India Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2015-2021) (US$ Million) Figure 70. Australia Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2015-2021) (K Units) Figure 71. Australia Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2015-2021) (US$ Million) Figure 72. Taiwan Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2015-2021) (K Units) Figure 73. Taiwan Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2015-2021) (US$ Million) Figure 74. Indonesia Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2015-2021) (K Units) Figure 75. Indonesia Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2015-2021) (US$ Million) Figure 76. Thailand Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2015-2021) (K Units) Figure 77. Thailand Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2015-2021) (US$ Million) Figure 78. Malaysia Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2015-2021) (K Units) Figure 79. Malaysia Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2015-2021) (US$ Million) Figure 80. Philippines Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2015-2021) (K Units) Figure 81. Philippines Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2015-2021) (US$ Million) Figure 82. Vietnam Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2015-2021) (K Units) Figure 83. Vietnam Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2015-2021) (US$ Million) Figure 84. Asia Pacific Opioid Induced Constipation (OIC) Drug Market Share by Type in 2019 Figure 85. Asia Pacific Opioid Induced Constipation (OIC) Drug Market Share by Application in 2019 Figure 86. Latin America Opioid Induced Constipation (OIC) Drug Sales Growth Rate 2015-2021 (K Units) Figure 87. Latin America Opioid Induced Constipation (OIC) Drug Revenue Growth Rate 2015-2021 (US$ Million) Figure 88. Latin America Opioid Induced Constipation (OIC) Drug Sales Market Share by Country in 2019 Figure 89. Latin America Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country in 2019 Figure 90. Mexico Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2015-2021) (K Units) Figure 91. Mexico Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2015-2021) (US$ Million) Figure 92. Brazil Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2015-2021) (K Units) Figure 93. Brazil Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2015-2021) (US$ Million) Figure 94. Argentina Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2015-2021) (K Units) Figure 95. Argentina Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2015-2021) (US$ Million) Figure 96. Latin America Opioid Induced Constipation (OIC) Drug Market Share by Type in 2019 Figure 97. Latin America Opioid Induced Constipation (OIC) Drug Market Share by Application in 2019 Figure 98. Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales Growth Rate 2015-2021 (K Units) Figure 99. Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue Growth Rate 2015-2021 (US$ Million) Figure 100. Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Country in 2019 Figure 101. Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country in 2019 Figure 102. Turkey Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2015-2021) (K Units) Figure 103. Turkey Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2015-2021) (US$ Million) Figure 104. Saudi Arabia Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2015-2021) (K Units) Figure 105. Saudi Arabia Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2015-2021) (US$ Million) Figure 106. U.A.E Opioid Induced Constipation (OIC) Drug Sales Growth Rate (2015-2021) (K Units) Figure 107. U.A.E Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2015-2021) (US$ Million) Figure 108. Middle East and Africa Opioid Induced Constipation (OIC) Drug Market Share by Type in 2019 Figure 109. Middle East and Africa Opioid Induced Constipation (OIC) Drug Market Share by Application in 2019 Figure 110. North America Opioid Induced Constipation (OIC) Drug Sales Growth Rate Forecast (2021-2027) (K Units) Figure 111. North America Opioid Induced Constipation (OIC) Drug Revenue Growth Rate Forecast (2021-2027) (US$ Million) Figure 112. Europe Opioid Induced Constipation (OIC) Drug Sales Growth Rate Forecast (2021-2027) (K Units) Figure 113. Europe Opioid Induced Constipation (OIC) Drug Revenue Growth Rate Forecast (2021-2027) (US$ Million) Figure 114. Asia Pacific Opioid Induced Constipation (OIC) Drug Sales Growth Rate Forecast (2021-2027) (K Units) Figure 115. Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue Growth Rate Forecast (2021-2027) (US$ Million) Figure 116. Latin America Opioid Induced Constipation (OIC) Drug Sales Growth Rate Forecast (2021-2027) (K Units) Figure 117. Latin America Opioid Induced Constipation (OIC) Drug Revenue Growth Rate Forecast (2021-2027) (US$ Million) Figure 118. Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales Growth Rate Forecast (2021-2027) (K Units) Figure 119. Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue Growth Rate Forecast (2021-2027) (US$ Million) Figure 120. Porter's Five Forces Analysis Figure 121. Channels of Distribution Figure 122. Distributors Profiles Figure 123. Bottom-up and Top-down Approaches for This Report Figure 124. Data Triangulation Figure 125. Key Executives Interviewed

Get Free Sample

Related Reports

Global Opioid Induced Constipation (OIC) Drug Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global Cushing's Syndrome Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Cushing's syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most ...
read more

Global Opioid Induced Constipation (OIC) Drug Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global Tyrosine Kinase Inhibitors Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Tyrosine kinase inhibitors are small molecules that bind to the receptor site of the kinase enzyme available at cell surface. Scope of the Report: The global tyrosine kinase inhibitors market is e ...
read more

Global Opioid Induced Constipation (OIC) Drug Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global 2D Chromatography Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

2D chromatography is a type of chromatographic technique in which the injected sample is separated by passing through two different separation stages. This is done by injecting the eluent from the fir ...
read more

Global Opioid Induced Constipation (OIC) Drug Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global Astringent Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Astringent are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure. Scope of the Report: In 2018, North America is expected to account for th ...
read more

Global Opioid Induced Constipation (OIC) Drug Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global Disintegrants Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Disintegrants are agents added to tablet (and some encapsulated) formulations to promote the breakup of the tablet (and capsule “slugs') into smaller fragments in an aqueous environment thereby ...
read more


Choose License Type

Single User - This is a single user license, allowing one specific user access to the product.

Multi User - This is a 1-5 user licence, allowing up to five users have access to the product.

Enterprise User - This is an enterprise license, allowing all employees within your organisation access to the product. The report will be emailed to you.


Cards For Payment

Why Choose us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports
  • Data Security
  • Your data is safe and secure
  • Vast Report Database
  • We have more than 2 Million reports in our database
  • Client Focused
  • Personalized updates and 24*7 support
  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support
  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie
  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports

Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
-VP of a Automotive division in Germany

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
-Product Manager at US based Manufacturer

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
-Marketing Manager at a pharma company in Belgium

How To Reach Us

Reach out to our most senior Sales Professional-
Jay Matthews

+1 513 549 5911 (U.S.),
    +44 203 318 2846 (U.K.)
sales@marketresearchvision.com
 

Our Clients






Market Research Vision

About Us


Market Research Vision is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & market research reports. Serving as a market research firm, we help our clients in finding: what’s next? We believe in finding creative and innovative solutions through customized and syndicated research reports.
Read More


Contact Us


 
sales@marketresearchvision.com


+1 513 549 5911 (U.S.)
+44 203 318 2846 (U.K.)